Rx.Health, a company formed to commercialize technology from the Mount Sinai Health System and the first to bring an enterprise-wide platform to prescribe Digital Medicine and Digital Therapeutics (DTx), announced today the appointment of Richard Strobridge as its Chief Executive Officer (CEO).
The Rx.Health platform unifies the fragmented digital health ecosystem to enable organizations to deliver anytime-anywhere healthcare, without changing the workflow. The platform includes more than 250 automated care pathways built by clinicians and including assets like DTx, curated health and wellness apps, AI chatbots, telehealth, and a comprehensive knowledge hub that can be “prescribed” to one patient or thousands directly from the electronic health record.
Strobridge is an award-winning digital health CEO with proven expertise in tech start-up development and growth in the healthcare and clinical research sectors. He has served as the founder or co-founder of seven companies and has had three successful digital health exits. Richard invented the first CE and FDA-approved wireless blood glucose meter and remote monitoring platform. He also co-founded a telesurgery company that was acquired by Stryker and is now a $400 million division.
“Rx.Health’s offerings have rapidly expanded during COVID to engage more than a million patients in digital monitoring and virtual care as well as enrollment in real-world registries. Rick is a leader in digital monitoring and is well-positioned to build on Rx.Health digital health formulary and EHR integration to create DTx Centers of Excellence through co-innovation with partnering health systems, health plans, and biopharma.” said Ashish Atreja, MD, Scientific Founder at Rx.Health and Chief Innovation Officer, Department of Medicine at the Icahn School of Medicine at Mount Sinai.
“Rx.Health offers healthcare systems the ability to extend patient care outside of the clinical setting through the power of digital health,” said Erik Lium, Ph.D., President of Mount Sinai Innovation Partners and Executive Vice President and Chief Commercial Innovation Officer at the Mount Sinai Health System. “I look forward to working with Richard Strobridge as Rx.Health continues to expand as a leader in digital medicine.”
“The four pillars of the Rx.Health platforms, namely curation, activation, engagement, and monitoring along with the focus on evidence-based, scalable digital therapeutics positions the company to play a key role in the shift from sick care to anywhere anytime care and research. I am honored and proud to lead such a unique organization.” said Strobridge.
About Rx.Health-
Rx.Health is changing the way both patients and providers think about digital medicine. A spin-out from the Mount Sinai Health System, Rx.Health provides the first EHR-connected digital health prescription platform that enables physicians to prescribe evidence-based mobile health applications, DTx, multi-media education, wearables, and remote monitoring programs to patients at the point of care. Health systems, health plans, life science or DTx companies interested in learning more can contact us at https://Rx.Health/
About the Mount Sinai Health System-
The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research, and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multi-specialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s”Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in the country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.
About Mount Sinai Innovation Partners (MSIP)-
MSIP is responsible for driving the real-world application and commercialization of Mount Sinai discoveries and inventions, and the development of research partnerships with industry. Our aim is to translate discoveries and inventions into health care products and services that benefit patients and society. MSIP is accountable for the full spectrum of commercialization activities required to bring Mount Sinai inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies building research, collaborations and partnerships with commercial and nonprofit entities, material transfer and confidentiality, coaching innovators to advance commercially relevant translational discoveries, and actively fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. For more information, visit www.ip.mountsinai.org.
